ArticleJournal of cancer research and clinical oncology2005

Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells.

Hiroshi Kamiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.